ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,238Medicare Part D Prescriptions Filled, Including Refills

Rank: 13 out of 1571

$1.11M Total Retail Price of All Prescriptions

Rank: 44 out of 1571

490 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
81% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

20% of this provider’s 490 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

1% of this provider’s 18,132 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $99 among peers.

Prescriptions per Patient

41 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
OMEPRAZOLE 840 768 1 4
SIMVASTATIN 829 740 2 1
WARFARIN SODIUM 724 667 3 14
LEVOTHYROXINE SODIUM 649 592 4 6
AMLODIPINE BESYLATE 542 508 5 2
DONEPEZIL HCL 542 542 5 24
METFORMIN HCL 497 445 7 9
ALENDRONATE SODIUM 467 448 8 22
GABAPENTIN 442 419 9 12
METOPROLOL TARTRATE 437 401 10 13
FUROSEMIDE 427 398 11 7
LOSARTAN POTASSIUM 400 380 12 17
LISINOPRIL 391 354 13 5
NAMENDA 336 336 14 37
HYDROCODONE-ACETAMINOPHEN 334 289 S3 15 3
CARVEDILOL 311 281 16 10
FAMOTIDINE 266 228 17 54
BENAZEPRIL HCL 254 222 18 32
TRAMADOL HCL 249 221 19 31
TAMSULOSIN HCL 241 228 20 11
JANUVIA 226 203 21 50
ENALAPRIL MALEATE 222 204 22 81
PRAVASTATIN SODIUM 205 179 23 26
ZOLPIDEM TARTRATE 201 188 24 20
ATORVASTATIN CALCIUM 197 177 25 8
DIOVAN 195 193 26 19
RISPERIDONE 188 145 27 89
GLIPIZIDE 178 169 28 53
ATENOLOL 176 159 29 15
POTASSIUM CHLORIDE 175 145 30 27
PANTOPRAZOLE SODIUM 175 167 30 23
MIRTAZAPINE 173 173 32 96
SPIRONOLACTONE 153 145 33 69
HYDROCHLOROTHIAZIDE 142 122 34 18
CLOPIDOGREL 135 131 35 21
SERTRALINE HCL 130 122 36 52
LANTUS 116 102 37 65
LEVETIRACETAM 116 93 37 60
METOPROLOL SUCCINATE 109 96 39 16
FLOVENT HFA 108 87 40 403
NOVOLIN R 107 93 41 256
CILOSTAZOL 106 103 42 222
CARBIDOPA-LEVODOPA 105 105 43 51
DIVALPROEX SODIUM 99 59 44 122
PLAVIX 98 97 45 28
LOVASTATIN 94 92 46 33
AZITHROMYCIN 94 89 46 58
CLOTRIMAZOLE 89 81 48 415
LEVEMIR 87 66 49 338
HYDRALAZINE HCL 87 75 49 82
ADVAIR DISKUS 86 71 51 43
ISOSORBIDE MONONITRATE ER 85 73 52 48
ACETAMINOPHEN-CODEINE 85 85 S3 52 105
DIGOXIN 84 82 54 35
QVAR 84 79 54 299
NOVOLOG 83 78 56 226
CYMBALTA 83 83 56 68
ESCITALOPRAM OXALATE 83 67 56 104
SPIRIVA 82 82 59 56
BENZTROPINE MESYLATE 80 57 R 60 170
PROAIR HFA 79 57 61 63
LACTULOSE 78 77 62 196
CITALOPRAM HBR 78 65 62 66
IPRATROPIUM-ALBUTEROL 76 74 64 274
LIDODERM 75 74 65 95
GLIMEPIRIDE 69 60 66 70
LOVAZA 66 63 67 90
NOVOLIN 70-30 60 51 68 363
PREDNISONE 60 42 68 34
ALBUTEROL SULFATE 60 53 68 166
FINASTERIDE 60 60 68 30
PROPRANOLOL HCL 58 58 72 176
BRIMONIDINE TARTRATE 57 57 73 103
METOCLOPRAMIDE HCL 57 32 73 116
ALLOPURINOL 56 54 75 36
HUMULIN R 56 44 75 309
HUMALOG 55 28 77 150
EXELON 54 54 78 158
FLUTICASONE PROPIONATE 54 37 78 41
OLANZAPINE 53 53 80 173
NYSTATIN 53 48 80 307
LOSARTAN-HYDROCHLOROTHIAZIDE 53 51 80 77
PHENYTOIN 53 23 80 532
TRAVATAN Z 53 53 80 46
RENVELA 52 33 85 57
MEGESTROL ACETATE 52 52 R 85 145
ACTOS 52 42 85 92
SINGULAIR 51 45 88 88
PROCRIT 51 51 88 228
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.